web analytics
0.4 C
Saturday, December 3, 2022

Comeback Time for Cannabis Science Inc (OTCMKTS:CBIS)

Cannabis Science Inc (OTCMKTS:CBIS) has been moving up steadily since reversing off $0.0101 lows. Currently under accumulation CBIS is one of the original pot stocks on the OTC and has been at the forefront of this incredible phenomenon since it began. The stock saw spectacular moves both in early 2012 and 2014 and currently sits just over all-time lows.

When the sector heats up as it looks to be doing now with a number of new states considering legalization and continued record revenues in Colorado CBIS is the perfect vehicle that knows how to market itself and sell the sizzle on the pot sector.

Cannabis Science Inc (OTCMKTS:CBIS) works with leading experts in drug development, medicinal characterization, and clinical research to develop, produce, and commercialize novel therapeutic approaches for the treatment for illnesses caused by infections as well as for age-related illness.

CBIS initial focus is on skin cancers, HIV/AIDS, and neurological conditions. The Company is proceeding with the research and development of its proprietary drugs as a part of this initial focus: CS-S/BCC-1, CS-TATI-1, and CS-NEURO-1, respectively.

Several years ago CBIS made a number of acquisitions in the cannabis sector that currently drive future growth. CBIS 2 most important drugs in development are:

The CS-S/BCC-1 drug program was launched in 2011 due to the “apparent success in 4 skin cancer patients who have self-administered cannabinoid based extracts topically to their skin cancers. These patients have experienced shrinking and apparent eradication of their skin cancer lesions.”

The drug CS-TATI-1 aims to target patients with drug-resistant HIV strains. The earliest article I could find relating to the launch of this program was in June 5, 2012, where the company loosely described a mission to “explore the commercial development of Phyto cannabinoid-based therapeutics for drug resistant HIV infection.”

To Find out the inside Scoop on CBIS Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

Looking at CBIS and all its vast and varied operating divisions, one might think they are a revenue generating power house but you would be very wrong; in fact CBIS has very limited operations, with minimal revenues to date and the Company continues to burn cash every quarter. This unfortunate situation has led to continued massive dilution with CBIS share count more than tripling over the past 3 years.

On March 4 CBIS announced Co-Founder, President & CEO Mr. Raymond C. Dabney, in an unprecedented move, will personally gift shareholders the proposed dividend shares. Mr. Dabney will be replacing both planned dividends with his own personal shares.

Mr. Dabney stated “This is really simple: our shareholders are our most important priority; this of course goes hand in hand with our operational success. Right now, we have outstanding successes — not all of which can be announced at this time — and we want ALL of our shareholders to benefit large or small from the Company’s achievements, as this was our purpose for the proportional dividend concept in the first place. We have so much to be proud of and ALL of our shareholders who have been with us through thick and thin over the years deserve to enjoy their piece of our successes. This momentous but simple message goes out to ALL investors and shareholders who have played such an important part of OUR successes.”

We have a Monster Pick Coming. Subscribe Right Now!

Currently trading at a $13 million market valuation CBIS has little assets or revenues and rising short term debt that has resulted in dilution over the years. But CBIS is an exciting story developing in small caps; the Company is specializing in the development of cannabis-based medicines and has a number of new exciting initiatives in the booming pot sector. CBIS is one of the original pot stocks with a long history of making spectacular 2000% plus moves that knows how to get its story into the national media so this is a great place to be when pot stocks heat up again. We will be updating on CBIS when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with CBIS.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in CBIS either long or short and we have not been compensated for this article.

More articles


Please enter your comment!
Please enter your name here

Latest article

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.